1995
DOI: 10.1016/0264-410x(95)00108-d
|View full text |Cite
|
Sign up to set email alerts
|

A follow-up study of combined vaccination with plasma-derived and recombinant hepatitis B vaccines in infants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
14
0

Year Published

1998
1998
2017
2017

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 27 publications
(15 citation statements)
references
References 21 publications
1
14
0
Order By: Relevance
“…There might be an overlapping period that the students received PDHBV and RYHBV combination. Lee et al . revealed that a combined vaccination with PDHBV and RYHBV was both protective and immunogenic, and did not affect the immunogenicity.…”
Section: Discussionmentioning
confidence: 99%
“…There might be an overlapping period that the students received PDHBV and RYHBV combination. Lee et al . revealed that a combined vaccination with PDHBV and RYHBV was both protective and immunogenic, and did not affect the immunogenicity.…”
Section: Discussionmentioning
confidence: 99%
“…In order to control the vertical transmission of HBV, neonatal immunisation programmes involving the use of immunoglobulin and hepatitis B vaccine have been adopted in many countries [28, 29]. In Hong Kong, this programme was introduced in 1983, following a prospective randomized study that had proved its efficacy [10, 30].…”
Section: Knowledge On Vertical Transmission and Its Preventionmentioning
confidence: 99%
“…Widespread vaccination further led to a dramatic reduction in the incidence of hepatocellular carcinoma in children between 6 and 15 years, and therefore the hepatitis B vaccine is also the first vaccine shown to be effective for the prevention of cancer [14]. However, high-risk infants who have been protected from hepatitis B by the administration of HBIg and HBV vaccine soon after birth still have a carrier rate of 5-10% [42].…”
Section: Hbsag-based Active and Passive Immunizationmentioning
confidence: 99%